← All stocks

vTv Therapeutics Inc.

VTVT Net buying
CIK 0001641489 #4196 in the set updated 21 Sep 2026
Bought (120 mo)
$60.72M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$100.05K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$100.05K
1 of 1 sales
Net
+$60.62M
+$60.62M against sales at will

By person

10 insiders · 59 transactions
0.1×

Paul Sekhri holds only 0.1 times base salary in stock. $84.78K of shares against $673.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Paul Sekhri last reported holding, valued at $16.96, the price Class A Common Stock was last bought or sold at on the open market here, on 18 Nov 2024.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
PERELMAN RONALD O
10% owner
$60.19M (41)
$100.05K (1)
+$60.09M
73,125,424
$1.24B
+87.5%
Nelson Rich S.
Acting Chief Executive Officer
$171.60K (2)
+$171.60K
60,000
$1.02M
SAVAS PAUL G
Director
$153.86K (7)
+$153.86K
91,781
$1.56M
+56.1%
SEKHRI PAUL J
Pres, CEO and Exec Chairperson
$83.81K (3)
+$83.81K
5,000
$84.78K
KOZLOV HERSH
Director
$65.65K (3)
+$65.65K
25,000
$423.92K
FRY JOHN A
Director
$50.74K (2)
+$50.74K
61,000
$1.03M
Samsara BioCapital GP, LLC entity
10% owner
206,784
$3.51M
−22.2%
BAKER BROS. ADVISORS LP entity
Director
135,946
$2.31M
−4.7%
AKKARAJU SRINIVAS
Director
106,000
$1.80M
KINDLER JEFFREY B
Director
35,000
$593.49K

No percentages here. vTv Therapeutics Inc. reports its share count only per share class, which the XBRL frames API does not carry.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 133
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 592,061
Sales filed before the plan box existed 1
History held since 14 Mar 2017